Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Polycom, Inc. (“Polycom” or the “Company”) (Nasdaq: PLCM) stock between July 24, 2012 and July 23, 2013 (the “Class Period”).
Click here to learn more about the investigation
, or call: 877-363-5972. There is no cost or obligation to you.
The Complaint alleges that during the Class Period the Company issued false and/or misleading statements and/or failed to disclose that: (a) the Company’s CEO, Andrew Miller, had submitted inappropriate and irregular expense submissions; (b) Miller violated the Company’s code of conduct and was subject to dismissal at all relevant times; (c) the Company did not have effective internal controls over its business operations, thus materially impacting the Company’s current and previous financial statements; (d) Miller’s conduct created a risk that he would be terminated from the Company, jeopardizing the Company’s future success; and (e) as a result of the above, the Company’s financial statements were materially false and misleading at all relevant times. On July 23, 2013, Polycom announced the resignation of Miller acknowledging the discovery by an Audit Committee of “certain irregularities” in Miller’s expense submissions.
If you suffered a loss in Polycom you have until September 24, 2013
to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at
or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit
Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.